Company profile PACB
Pacific Biosciences of California Inc
pacbio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. we provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges. our strength comes from the dedication of our people, who are fueled by a d...esire to effect real, positive change. with a focus on the future and an experienced, passionate team, we are motivated to continue to redefine what is possible in genomics.
Show More
After 39 days of this quarter the interest is at 205.0. Based on that we can calculate that during remaining 52 days it will total up to 478.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 167 | 227 35.9% QoQ | 239 5.3% QoQ | 266 11.3% QoQ |
| 2020 | 314 88.0% YoY 18.0% QoQ | 213 -6.2% YoY -32.2% QoQ | 278 16.3% YoY 30.5% QoQ | 212 -20.3% YoY -23.7% QoQ |
| 2021 | 217 -30.9% YoY 2.4% QoQ | 233 9.4% YoY 7.4% QoQ | 491 76.6% YoY 110.7% QoQ | 234 10.4% YoY -52.3% QoQ |
| 2022 | 445 105.1% YoY 90.2% QoQ | 355 52.4% YoY -20.2% QoQ | 375 -23.6% YoY 5.6% QoQ | 386 65.0% YoY 2.9% QoQ |
| 2023 | 401 -9.9% YoY 3.9% QoQ | 429 20.8% YoY 7.0% QoQ | 361 -3.7% YoY -15.9% QoQ | 483 25.1% YoY 33.8% QoQ |
| 2024 | 205 -48.9% YoY -57.6% QoQ | - | - | - |
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
The average 5 years interest of pacbio sequencing was 25.02 per week. The last year interest of pacbio sequencing compared to the last 5 years has changed by 28.66%. The interest for pacbio sequencing is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 66.18%.
Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for PACB
Company name: Pacific Biosciences of California Inc
Sector: Manufacturing
Company's websiteHyperchartsYahoo FinanceMarketWatchStockTwitsSEC FilingsSwaggyStocksLatest articles
2026-05-11T13:46:35Z
Analyst Upgrades
Barclays Maintains Underweight on Pacific Biosciences, Raises Price Target to $1.52026-05-11T13:05:00Z
GlobeNewswire
HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss2026-05-07T20:05:00Z
GlobeNewswire
PacBio Announces First Quarter 2026 Financial Results2026-04-21T13:05:00Z
GlobeNewswire
PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing2026-04-16T20:05:00Z
GlobeNewswire
PacBio to Report First Quarter 2026 Financial Results on May 7, 20262026-04-15T13:05:00Z
GlobeNewswire
PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples2026-03-06T14:04:09Z
Analyst Upgrades
Barclays Downgrades Pacific Biosciences to Underweight, Lowers Price Target to $1.52026-03-05T13:30:00Z
GlobeNewswire
PacBio Announces the Appointment of Chris Gibson to the Board of Directors2026-02-24T14:05:00Z
GlobeNewswire
PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research2026-02-18T21:05:00Z
GlobeNewswire
PacBio to Participate in the TD Cowen 46th Annual Health Care Conference2026-02-12T21:05:00Z
GlobeNewswire
PacBio Announces Fourth Quarter and Full Year 2025 Financial Results2026-02-12T12:00:00Z
GlobeNewswire
PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner2026-02-02T14:05:00Z
GlobeNewswire
PacBio Completes Sale of Short-Read Sequencing Assets2026-01-27T21:05:00Z
GlobeNewswire
PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 20262026-01-12T14:15:00Z
GlobeNewswire
PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases